成人急性低氧性呼吸衰竭的无创氧疗策略:系统评价与网状Meta分析
该系统评价与网状Meta分析纳入36项随机对照试验共7046例急性低氧性呼吸衰竭成人患者,比较多种无创氧疗策略。结果显示头盔CPAP可能降低死亡率,经鼻高流量氧疗可能减少气管插管需求,头盔无创通气可能缩短ICU住院时间。
要点
- 与标准氧疗相比,头盔CPAP可能降低死亡率(每1000例减少231例死亡,95%CI 126-273,中等确定性)。
- 经鼻高流量氧疗可能减少有创机械通气需求(每1000例减少103.5例事件,95%CI 40.5-157.5,中等确定性)。
- 头盔双水平通气可能缩短ICU住院时间(减少4.84天,95%CI 2.33-7.36天,低确定性)。
核心结论
- 头盔接口无创通气可能降低死亡率和机械通气风险,并缩短住院及ICU停留时间。
- 经鼻高流量氧疗可能降低有创机械通气风险,舒适度可能与标准氧疗相当。
研究设计与样本
- 系统评价检索Medline、Embase、Cochrane CENTRAL、CINAHL、Web of Science、MedRxiv和Research Square,自建库至2022年10月1日。
- 采用随机效应频率学网状Meta分析,结果以每1000例患者的绝对风险差表示,并使用GRADE框架评价证据确定性。
- 共纳入36项试验,7046例患者。
主要发现
- 头盔CPAP与标准氧疗相比可能降低死亡率(每1000例减少231例死亡,95%CI 126-273,中等确定性)。
- 经鼻高流量氧疗可能减少有创机械通气需求(每1000例减少103.5例事件,95%CI 40.5-157.5,中等确定性)。
- 所有无创氧疗策略与标准氧疗相比可能缩短住院时间(低确定性)。
- 头盔双水平通气可能缩短ICU住院时间(减少4.84天,95%CI 2.33-7.36天,低确定性)。
- 头盔CPAP对ICU住院时间的影响不确定(减少1.74天,95%CI 减少4.49天至增加1.01天,低确定性)。
临床怎么用
- 在成人急性低氧性呼吸衰竭中,可考虑头盔CPAP以降低死亡率,或经鼻高流量氧疗以减少插管需求。
- 头盔双水平通气可能有助于缩短ICU住院时间,但证据确定性较低。
局限性
- 部分结局的证据确定性为低,需进一步研究明确各接口在急性低氧性呼吸衰竭中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Several recently published randomized controlled trials have evaluated various noninvasive oxygenation strategies for the treatment of acute hypoxemic respiratory failure. RESEARCH QUESTION: Which available noninvasive oxygen strategies are effective for acute hypoxic respiratory failure? STUDY DESIGN AND METHODS: A systematic review of Medline, Embase, Cochrane CENTRAL, CINAHL, Web of Science, MedRxiv, and Research Square was conducted from inception to October 1, 2022. A random effects frequentist network meta-analysis was performed, and the results are presented using absolute risk difference per 1,000 patients. The Grading of Recommendations, Assessment, Development and Evaluation framework was used to rate the certainty of the evidence. Mortality, invasive mechanical ventilation, duration of hospitalization and ICU stay, ventilator-free days, and level of comfort are reported. RESULTS: Thirty-six trials (7,046 patients) were included. It was found that helmet CPAP probably reduces mortality compared with standard oxygen therapy (SOT) (231 fewer deaths per 1,000; 95% CI, 126-273 fewer) (moderate certainty). A high-flow nasal cannula (HFNC) probably reduces the need for invasive mechanical ventilation (103.5 fewer events per 1,000; 95% CI, 40.5-157.5 fewer) (moderate certainty). All noninvasive oxygenation strategies may reduce the duration of hospitalization as compared with SOT (low certainty). Helmet bilevel ventilation (4.84 days fewer; 95% CI, 2.33-7.36 days fewer) and helmet CPAP (1.74 days fewer; 95% CI, 4.49 fewer-1.01 more) may reduce the duration of ICU stay as compared with SOT (both low certainty). SOT may be more comfortable than face mask noninvasive ventilation and no different in comfort compared with an HFNC (both low certainty). INTERPRETATION: A helmet interface for noninvasive ventilation probably reduces mortality and the risk of mechanical ventilation, as well as the duration of hospital and ICU stay. An HFNC probably reduces the risk of invasive mechanical ventilation and may be as comfortable as SOT. Further research is necessary to understand the role of these interfaces in acute hypoxemic respiratory failure.
引用
- Pitre T, Zeraatkar D, Kachkovski GV, et al. Noninvasive Oxygenation Strategies in Adult Patients With Acute Hypoxemic Respiratory Failure: A Systematic Review and Network Meta-Analysis. Chest. 2023. PMID: 37085046. doi:10.1016/j.chest.2023.04.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。